Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IRE1 activating compounds for use in therapy

IRE1 activating compounds for use in therapy

US Patent 11426402 · Granted Aug 30, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfur (VI) fluoride compounds and methods for the preparation thereof2025
Stabilization of amyloidogenic immunoglobulin light chains2024
Sulfur (VI) fluoride compounds and methods for the preparation thereof2021
Regulators of the endoplasmic reticulum proteostasis network2021
Regulators of the endoplasmic reticulum proteostasis network2021
Regulators of the endoplasmic reticulum proteostasis network2021
Regulators of the endoplasmic reticulum proteostasis network2021
Sulfur(VI) fluoride compounds and methods for the preparation thereof2020
Sulfur(VI) fluoride compounds and methods for the preparation thereof2018
Transthyretin antibodies and uses thereof2017
Small molecules that covalently modify transthyretin2017
Reliable stabilization of N-linked polypeptide native states with enhanced aroma2014